DK170334B1 - 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater - Google Patents
2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater Download PDFInfo
- Publication number
- DK170334B1 DK170334B1 DK133687A DK133687A DK170334B1 DK 170334 B1 DK170334 B1 DK 170334B1 DK 133687 A DK133687 A DK 133687A DK 133687 A DK133687 A DK 133687A DK 170334 B1 DK170334 B1 DK 170334B1
- Authority
- DK
- Denmark
- Prior art keywords
- propyl
- alkyl
- hydroxy
- pyridon
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH108486 | 1986-03-17 | ||
CH108486 | 1986-03-17 | ||
CH226986 | 1986-06-04 | ||
CH226986 | 1986-06-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK133687D0 DK133687D0 (da) | 1987-03-16 |
DK133687A DK133687A (da) | 1987-09-18 |
DK170334B1 true DK170334B1 (da) | 1995-08-07 |
Family
ID=25686601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK133687A DK170334B1 (da) | 1986-03-17 | 1987-03-16 | 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater |
Country Status (18)
Country | Link |
---|---|
US (1) | US4863938A (fi) |
EP (1) | EP0239533B1 (fi) |
JP (1) | JPH0662566B2 (fi) |
KR (1) | KR910000658B1 (fi) |
AU (1) | AU601401B2 (fi) |
CA (1) | CA1312869C (fi) |
DE (1) | DE3781705D1 (fi) |
DK (1) | DK170334B1 (fi) |
ES (1) | ES2052601T3 (fi) |
FI (1) | FI86634C (fi) |
GR (1) | GR3006476T3 (fi) |
HU (1) | HU201913B (fi) |
IE (1) | IE59812B1 (fi) |
IL (1) | IL81903A0 (fi) |
NO (1) | NO172984C (fi) |
NZ (1) | NZ219629A (fi) |
PH (1) | PH25903A (fi) |
PT (1) | PT84490B (fi) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3073851A (en) * | 1957-12-04 | 1963-01-15 | Hoffmann La Roche | Formamidines of primary amines |
NL253634A (fi) * | 1959-07-10 | |||
US3184482A (en) * | 1961-11-20 | 1965-05-18 | Hoffmann La Roche | Anthraquinone formamidines of primary amines |
US3182053A (en) * | 1961-11-20 | 1965-05-04 | Hoffmann La Roche | Pyridine formamidines of primary amines |
US3133078A (en) * | 1961-11-20 | 1964-05-12 | Hoffmann La Roche | Oxazole formamidines of primary amines |
GB1256714A (fi) * | 1968-06-27 | 1971-12-15 | ||
US4186264A (en) * | 1976-04-20 | 1980-01-29 | Pfizer Inc. | Triazapentadienes as acaricides |
US4128652A (en) * | 1976-04-20 | 1978-12-05 | Pfizer Inc. | Triazapentadienes as acaricides |
-
1987
- 1987-03-11 ES ES87810136T patent/ES2052601T3/es not_active Expired - Lifetime
- 1987-03-11 EP EP87810136A patent/EP0239533B1/de not_active Expired - Lifetime
- 1987-03-11 DE DE8787810136T patent/DE3781705D1/de not_active Expired - Lifetime
- 1987-03-13 FI FI871126A patent/FI86634C/fi not_active IP Right Cessation
- 1987-03-13 CA CA000531950A patent/CA1312869C/en not_active Expired - Fee Related
- 1987-03-16 DK DK133687A patent/DK170334B1/da not_active Application Discontinuation
- 1987-03-16 IE IE68787A patent/IE59812B1/en not_active IP Right Cessation
- 1987-03-16 PT PT84490A patent/PT84490B/pt not_active IP Right Cessation
- 1987-03-16 HU HU871139A patent/HU201913B/hu not_active IP Right Cessation
- 1987-03-16 KR KR1019870002341A patent/KR910000658B1/ko not_active IP Right Cessation
- 1987-03-16 NO NO871075A patent/NO172984C/no unknown
- 1987-03-16 IL IL81903A patent/IL81903A0/xx not_active IP Right Cessation
- 1987-03-16 NZ NZ219629A patent/NZ219629A/xx unknown
- 1987-03-17 JP JP62060234A patent/JPH0662566B2/ja not_active Expired - Lifetime
- 1987-03-17 AU AU70070/87A patent/AU601401B2/en not_active Ceased
-
1988
- 1988-02-17 PH PH36520A patent/PH25903A/en unknown
- 1988-10-31 US US07/266,311 patent/US4863938A/en not_active Expired - Fee Related
-
1992
- 1992-12-09 GR GR920402188T patent/GR3006476T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0662566B2 (ja) | 1994-08-17 |
CA1312869C (en) | 1993-01-19 |
US4863938A (en) | 1989-09-05 |
PH25903A (en) | 1991-12-19 |
IE870687L (en) | 1987-09-17 |
NO871075D0 (no) | 1987-03-16 |
NZ219629A (en) | 1990-03-27 |
AU601401B2 (en) | 1990-09-13 |
DK133687D0 (da) | 1987-03-16 |
NO172984C (no) | 1993-10-06 |
PT84490A (en) | 1987-04-01 |
PT84490B (pt) | 1989-11-10 |
ES2052601T3 (es) | 1994-07-16 |
HUT43823A (en) | 1987-12-28 |
JPS62226959A (ja) | 1987-10-05 |
NO871075L (no) | 1987-09-18 |
FI871126A0 (fi) | 1987-03-13 |
FI86634B (fi) | 1992-06-15 |
DK133687A (da) | 1987-09-18 |
FI871126A (fi) | 1987-09-18 |
EP0239533A1 (de) | 1987-09-30 |
KR910000658B1 (ko) | 1991-01-31 |
KR870008850A (ko) | 1987-10-21 |
FI86634C (fi) | 1992-09-25 |
NO172984B (no) | 1993-06-28 |
IE59812B1 (en) | 1994-04-06 |
HU201913B (en) | 1991-01-28 |
DE3781705D1 (de) | 1992-10-22 |
IL81903A0 (en) | 1987-10-20 |
EP0239533B1 (de) | 1992-09-16 |
GR3006476T3 (fi) | 1993-06-21 |
AU7007087A (en) | 1987-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4171363A (en) | 1,2,3-Thiadiazole process | |
US4101548A (en) | 1,2,3-Thiadiazole amides | |
DE69411317T2 (de) | Indoloylguanidinderivate als Inhibitoren des Natrium-Protonen Austauschs | |
EP0260817A1 (en) | Quinazolinediones and pyridopyrimidinediones | |
NO170883B (no) | Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater | |
US5110818A (en) | Anticonvulsive substituted-9-benzyl-9h-purines | |
JP2556722B2 (ja) | 新規なスルホンアミド化合物 | |
IE57057B1 (en) | Carboxamides,process for their preparation and pharmaceutical preparations containing them | |
WO2003103671A1 (en) | Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom | |
EP0700911B1 (en) | Imidazole derivatives having anti-HIV activity | |
EP0228845A2 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
CZ113393A3 (en) | Hiv protease inhibitor, useful for aids treatment, process of its preparation and pharmaceutical preparation in which said inhibitor is comprised | |
US4868175A (en) | 4-Benzyl-1-(2H)-phthalazineone derivatives having an amino acid radical | |
JPH01313469A (ja) | キナゾリン、その製法及びこれを含有する抗腫瘍作用を有する製薬学的組成物 | |
US5576327A (en) | Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds | |
DK156722B (da) | Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater | |
JPH07188197A (ja) | オキサゾール誘導体 | |
DK170334B1 (da) | 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater | |
NZ206696A (en) | 1,2,3-triazole derivatives and pharmaceutical compositions | |
US5707979A (en) | Phosphinic acid derivatives, their preparation and their use | |
NO165493B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner. | |
US20100087496A1 (en) | Novel cinnamic amide derivatives useful as ion channel modulators | |
DK141749B (da) | Analogifremgangsmåde til fremstilling af pyridincarboxamidoethylbenzensulfonylurinstof-forbindelser. | |
CA2276310C (en) | Process for the production of tetrazolylbenzopyrans | |
JP2001525398A (ja) | 選択的β3アドレナリン作動性アゴニスト |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment | ||
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed | ||
AHB | Application shelved due to non-payment |